Evidence map›Paper›PMID 25009318›Full record

ArticleJournal of cancer research and clinical oncology2014

Genetic association of osteopontin (OPN) and its receptor CD44 genes with susceptibility to Chinese gastric cancer patients.

Yue Qiu, Yuan Hu, Zuo-Yang Zhang, Lei Ye, Fei-Hong Xu, Marion E Schneider, Xue-Ling Ma, Yi-Xin Du, Xian-Bo Zuo, Fu-Sheng Zhou and 6 more

Open access · greenAbstract read
In one paragraph

Article in Journal of cancer research and clinical oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. CD44 as a tumor biomarker and therapeutic target.Experimental hematology & oncology · 2020
    Review
  7. Article
  8. Article
  9. Association of Two CD44 Polymorphisms with Clinical Outcomes of Gastric Cancer PatientsAsian Pacific journal of cancer prevention : APJCP · 2018
    Article
  10. Review
  11. Overexpression of osteopontin promotes cell proliferation and migration in human nasopharyngeal carcinoma and is associated with poor prognosis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2018
    Article
  12. Article
  13. Indian journal of clinical biochemistry : IJCB · 2017
    Article
  14. Article
  15. Clinicopathological Significance of Osteopontin in Cholangiocarcinoma Cases.Asian Pacific journal of cancer prevention : APJCP · 2016
    Article
  16. Article
  17. Role of cancer stem cell marker CD44 in gastric cancer: a meta-analysis.International journal of clinical and experimental medicine · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 3 countries.

Yue QiuDepartment of Dermatology, The First Affiliated Hospital, Anhui Medical University, Hefei, 230032, People's Republic of China.
Yuan Hu
Zuo-Yang Zhang
Lei Ye
Fei-Hong Xu
Marion E Schneider
Xue-Ling Ma
Yi-Xin Du
Xian-Bo Zuo
Fu-Sheng Zhou
Gang Chen
Xu-Shi Xie
Yan Zhang
Hong-Zhen Xia
Ji-Feng Wu
Wei-Dong Du
Anhui Medical University · CNUniversity Hospital Ulm · DEIcahn School of Medicine at Mount Sinai · USAcura Kliniken · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose(1) To investigate associations between single nucleotide polymorphisms (SNPs) in osteopontin (OPN) and its receptor-cluster of differentiation 44 (CD44) genes and gastric cancer susceptibility. (2) To explore the correlation of OPN and CD44 expression of gastric cancer.

methodsWe detected 26 SNPs of the genes in gastric cancer patients from the Chinese Han population by Sequenom technique and performed expression of OPN in combination with CD44 in 243 tissues samples of the cases by tissue microarray and immunohistochemistry (IHC).

resultsWe found that the minor alleles of OPN rs4754C>T and OPN rs9138C>A remained strongly associated with decreased gastric cancer risk (P = 1.53 × 10(-4), odds ratio (OR) 0.642, 95 % confidence interval (CI) 0.511-0.808 and P = 1.59 × 10(-4), OR 0.642, 95 %CI 0.510-0.809). OPN variant rs1126772A>G and CD44 variant rs353639A>C significantly contributed to elevated risk of gastric cancer (P = 0.042, OR 1.279, 95 % CI 1.008-1.622 and P = 0.047, OR 1.334, 95 % CI 1.003-1.772). Haplotypes of OPN and CD44 variants significantly influenced risk of gastric cancer. Clinical data indicated that rs4754 and rs9138 of OPN were significantly associated with smoking (P = 0.029, OR 0.343, 95 % CI 0.127-0.926 and P = 0.029, OR 0.343, 95 %CI 0.127-0.926) and OPN rs1126772 revealed associations with tumor-node-metastasis (TNM) stage (P = 0.025, OR 1.765, 95 % CI 1.073-2.905) and tumor differentiation (P = 0.031, OR 1.722, 95 % CI 1.049-2.825). OPN expression was observed in 133 of the 243 cases (54.7 %) by IHC and was correlated with serosa invasion (P = 0.013), TNM stage (P = 0.003) and lymph node metastasis (P = 0.002). CD44 expression was found in 92 of the 243 cases (37.9 %) and was associated with tumor size (P = 0.005) and lymph node metastasis (P = 0.023), respectively. The OPN expression displayed a positive association with CD44 (P = 0.01, r s = 0.164).

conclusionsWe found that the polymorphisms rs4754, rs9138 and rs1126772 of OPN gene and rs353639 of CD44 gene were significantly associated with gastric cancer. Our IHC data indicated that interaction of OPN and CD44 protein would promote progression and metastasis of gastric cancer.

Indexed as

Genetic Predisposition to DiseaseAdultAgedAged, 80 and overFemaleHaplotypesHumansHyaluronan ReceptorsLinkage DisequilibriumLogistic ModelsMaleMiddle AgedOsteopontinPolymorphism, Single NucleotideStomach NeoplasmsCD44 protein, humanHyaluronan ReceptorsOsteopontin

Identifiers

PMID25009318
PMCPMC11823936
OpenAlexW2147410856

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.